These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians. Kunej T, Globocnik Petrovic M, Dovc P, Peterlin B, Petrovic D. Folia Biol (Praha); 2004; 50(5):157-8. PubMed ID: 15581067 [Abstract] [Full Text] [Related]
3. Common polymorphisms of the peroxisome proliferator-activated receptor-gamma (Pro12Ala) and peroxisome proliferator-activated receptor-gamma coactivator-1 (Gly482Ser) and the response to pioglitazone in Chinese patients with type 2 diabetes mellitus. Hsieh MC, Lin KD, Tien KJ, Tu ST, Hsiao JY, Chang SJ, Lin SR, Shing SJ, Chen HC. Metabolism; 2010 Aug; 59(8):1139-44. PubMed ID: 20045142 [Abstract] [Full Text] [Related]
5. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects. Ruchat SM, Weisnagel SJ, Vohl MC, Rankinen T, Bouchard C, Pérusse L. Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736 [Abstract] [Full Text] [Related]
6. Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians. Ma J, Li Y, Zhou F, Xu X, Guo G, Qu Y. Mol Vis; 2012 Oct; 18():2352-60. PubMed ID: 22993484 [Abstract] [Full Text] [Related]
7. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population. Meshkani R, Taghikhani M, Larijani B, Bahrami Y, Khatami S, Khoshbin E, Ghaemi A, Sadeghi S, Mirkhani F, Molapour A, Adeli K. Clin Chem Lab Med; 2007 Oct; 45(4):477-82. PubMed ID: 17439324 [Abstract] [Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis. Maver A, Medica I, Salobir B, Tercelj-Zorman M, Sabovic M, Petrovic D, Peterlin B. Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258 [Abstract] [Full Text] [Related]
12. Alanine variant of the Pro12Ala polymorphism of the PPARgamma gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes. Malecki MT, Cyganek K, Mirkiewicz-Sieradzka B, Wolkow PP, Wanic K, Skupien J, Solnica B, Sieradzki J. Diabetes Res Clin Pract; 2008 Apr; 80(1):139-45. PubMed ID: 18077048 [Abstract] [Full Text] [Related]
13. A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia. Danawati CW, Nagata M, Moriyama H, Hara K, Yasuda H, Nakayama M, Kotani R, Yamada K, Sakata M, Kurohara M, Wiyono P, Asdie H, Sakaue M, Taniguchi H, Yokono K. Diabetes Metab Res Rev; 2005 Apr; 21(5):465-9. PubMed ID: 15739197 [Abstract] [Full Text] [Related]
14. The Gly482Ser variant of the PPARGC1 gene is associated with Type 2 diabetes mellitus in northern Chinese, especially men. Sun L, Yang Z, Jin F, Zhu XQ, Qu YC, Shi XH, Wang L. Diabet Med; 2006 Oct; 23(10):1085-92. PubMed ID: 16978372 [Abstract] [Full Text] [Related]
15. The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects. Fanelli M, Filippi E, Sentinelli F, Romeo S, Fallarino M, Buzzetti R, Leonetti F, Baroni MG. Dis Markers; 2005 Oct; 21(4):175-80. PubMed ID: 16403952 [Abstract] [Full Text] [Related]
17. Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis. Liu G, Zhou TB, Jiang Z, Zheng D, Yuan F, Li Y, Hu H, Chen Z. J Recept Signal Transduct Res; 2014 Apr; 34(2):131-6. PubMed ID: 24303936 [Abstract] [Full Text] [Related]
19. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity. Swarbrick MM, Chapman CM, McQuillan BM, Hung J, Thompson PL, Beilby JP. Eur J Endocrinol; 2001 Mar; 144(3):277-82. PubMed ID: 11248748 [Abstract] [Full Text] [Related]
20. Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity. Radha V, Vimaleswaran KS, Babu HN, Abate N, Chandalia M, Satija P, Grundy SM, Ghosh S, Majumder PP, Deepa R, Rao SM, Mohan V. Diabetes Care; 2006 May; 29(5):1046-51. PubMed ID: 16644635 [Abstract] [Full Text] [Related] Page: [Next] [New Search]